- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01282983
Study of Digestive Tolerance of Orange Juice With Fibers
January 24, 2011 updated by: University of Sao Paulo
Dietary fiber (commonly called bulk or roughage) is the edible nondigestible component of carbohydrate and lignin naturally found in plant food; however, bacteria in the lower gut may metabolize part of it.
Epidemiological studies have found that fiber intake in the population is below the suggested recommendations.
The beneficial effects of the fibers in human health are recognized.
The regular intake of dietary fiber has an important role in the intestinal function increasing the intestinal fecal and reducing the transit time along the intestine; collaborates with the LDL-cholesterol plasmatic reduction by increasing fecal excretion of cholesterol and bile acids, decreases postprandial glucose in healthy, diabetics and insulin resistant people, reduces the risk for developing certain cancers, promotes satiety, helps with weight loss, and exerts immunomodulatory effect.
However, fiber intake may be associated with adverse effects such as flatulence, bloating, cramps, and daily consumption of orange juice to bring digestive problems associated with acidity and heartburn, epigastric burning.
Then it becomes of interest to study the tolerance of a new orange juice product fortified with mixed fibers (fructooligosaccharides, resistant dextrin, polydextrose and lactulose).
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Monocentric, double blind, randomized, two parallel arms controlled placebo study.
200 healthy women from 18 to 45 years old, without functional digestive disorders or diagnosed digestive disease will take part in the study.
The study consists of 21 days consumption of Orange juice.
The participants will be randomized in two groups: placebo (Orange juice without fiber - control) and study group (Orange juice fortified with fiber mix).
In both groups, the volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner).
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
SP
-
São Paulo, SP, Brazil
- Recruiting
- University of Sao Paulo
-
Contact:
- Dan L Waitzberg, MD PhD
- Email: dan@ganep.com.br
-
Contact:
- Lilian M Horie, RD MsC
- Email: mikahorie@gmail.com
-
Principal Investigator:
- Dan L Waitzberg, MD PhD
-
Sub-Investigator:
- Ana P Muniz Pereira, RD
-
Sub-Investigator:
- Cecilia Jardini Marques, RD
-
Sub-Investigator:
- Glaucia M Shiroma, RD
-
Sub-Investigator:
- Juliana Lopes Frias, RD
-
Sub-Investigator:
- Lidiane A Catalani, RD
-
Sub-Investigator:
- Lilian M Horie, RD MsC
-
Sub-Investigator:
- Liria Nubia Alvarenga, RD
-
Sub-Investigator:
- Maria Carolina Gonçalves Dias, RD MsC
-
Sub-Investigator:
- Maria Cláudia Ortolani, RD
-
Sub-Investigator:
- Maria de Lourdes Teixeira da Silva, MD MsC
-
Sub-Investigator:
- Maria Manuela Ferreira Alves, RD
-
Sub-Investigator:
- Priscila Carasin Garla, RD
-
Sub-Investigator:
- Ricardo Alexandre Garib, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Healthy
- Tolerate the intake of orange juice routinely (at least twice/month)
- Do not use antibiotics, industrial fibers or supplements containing industrialized fibers, prebiotics and probiotics for 30 days before the start of the study
- BMI between 18,5 a 29,9 Kg/m2
- Body weight stable during the last two months
- Able to have good communication with the researcher
- Understand and agree with the rules of the study
- Making use of some contraceptive method
- Non-smokers (less than five cigarettes/day)
Exclusion Criteria:
- Illiterate
- Severe alcoholics
- Allergy to orange and its juice
- Any other allergy or food intolerance
- Disease or disorder of the upper digestive tract diagnosed and treated in the last twelve months
- Inflammatory bowel diseases
- Irritable bowel syndrome
- To have diarrhea (three liquid evacuations a day)
- Pregnancy
- Lactation
- Any history of eating disorder
Declared diseases:
- Renal insufficiency
- Hepatic Insufficiency
- Chronic Heart Failure
- Other disease which in the opinion of the investigator might be inconsistent with the study
- Be in dialysis process
- Chronic renal failure
- History or evidence of organic disease of the gastrointestinal tract
- History of cancer within five previous years (except basal cell carcinoma well treated or cervical carcinoma in situ)
- History or evidence of metabolic disturbs
- History of gastric surgery intervention (except appendectomy)
- Being under some weight loosing process or diet
- Refuse to sign the Informed Consent Term
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo
|
The study consists of 21 days consumption of Orange juice.
The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) without fiber.
|
|
Active Comparator: fiber
|
The study consists of 21 days consumption of Orange juice.
The volunteers will be instructed to consume 200ml of juice twice a day (1 pack of 200ml at lunch and one at dinner) with 4grams of fiber in each pack.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of stool - Chart
Time Frame: Frequency of stool - Chart
|
Bristol scale with classification type 1 to type 7 will be used for self-information on daily frequency of bowel movements and consistency of the feces.
|
Frequency of stool - Chart
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unwanted symptoms classification
Time Frame: Unwanted symptoms classification
|
The daily graduation of nuisance for abdominal pain, flatulence, abdominal distension, nausea and vomiting using the classification for unwanted symptoms, with 4-point scale, after 3 weeks consumption of product with the information obtained with the standard orange juice consumption from the participant diary
|
Unwanted symptoms classification
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Dan L Waitzberg, MD PhD, University of Sao Paulo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Anticipated)
February 1, 2011
Study Completion (Anticipated)
September 1, 2011
Study Registration Dates
First Submitted
January 20, 2011
First Submitted That Met QC Criteria
January 24, 2011
First Posted (Estimate)
January 25, 2011
Study Record Updates
Last Update Posted (Estimate)
January 25, 2011
Last Update Submitted That Met QC Criteria
January 24, 2011
Last Verified
October 1, 2010
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IKEA2010
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Digestive Alteration [PE]
-
Saavsus, Inc.Oregon Research InstituteRecruitingTeacher Self-efficacy for Teaching PE | Teacher PE Instruction | Student PE Enjoyment | Student Physical Activity | Student PE SatisfactionUnited States
-
Bayside HealthUnknown
-
BioMed Valley Discoveries, IncTerminatedAdvanced Solid Tumor | MAP2K1 Gene Mutation | BRAF Gene Mutation | MEK Mutation | BRAF Gene Alteration | MEK Alteration | MAP2K1 Gene Alteration | MAP2K2 Gene Mutation | MAP2K2 Gene AlterationUnited States
-
Assiut UniversityNot yet recruiting
-
Cairo UniversityUnknown
-
Danone Asia Pacific Holdings Pte, Ltd.CompletedImmunologic Activity Alteration
-
University of ThessalyUnknownThyroidectomy | Voice Alteration | Swallowing AlterationGreece
-
Children's Hospital of PhiladelphiaNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
United States Army Research Institute of Environmental...United States Department of DefenseCompletedDietary Modification | Bone AlterationUnited States
-
National Taiwan University HospitalCompletedAlteration of Cognitive FunctionTaiwan
Clinical Trials on Fiber
-
Stanford UniversityNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingPrebioticsUnited States
-
Center of Food and Fermentation TechnologiesCompleted
-
University of Texas Southwestern Medical CenterCompletedNon-Insulin-Dependent Diabetes Mellitus
-
Universidade de Passo FundoCompletedDietary Habits | Bowel Dysfunction
-
Wageningen University and ResearchJ. Rettenmaier & Sohne GmbH & Co. KGCompleted
-
Washington University School of MedicineCompletedMicrobial ColonizationUnited States
-
Tufts UniversityCompletedSarcopenia | Microbial Colonization | Dietary ExposureUnited States
-
BrightseedUniversity of Arkansas; Biofortis Mérieux NutriSciencesActive, not recruiting
-
University of Missouri-ColumbiaRecruiting